Bioactive products of phospholipid oxidation: Isolation, identification, measurement and activities

Free Radical Biology and Medicine

Volumn 28, Issue 12, 2000, Pages 1751-1761

  Subbanagounder, Ganesamoorthy ^a   Watson, Andrew D ^a   Berliner, Judith A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Free radical; LDL oxidation; Oxidized phospholipids

Indexed keywords

ALDEHYDE; ANTIBODY; ARACHIDONIC ACID; FREE RADICAL; HYDROXYICOSATETRAENOIC ACID; LINOLEIC ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A1; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ATHEROGENESIS; ATHEROSCLEROSIS; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; REVIEW; SOLID PHASE EXTRACTION; THIN LAYER CHROMATOGRAPHY;

EID: 0034659139     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00233-1     Document Type: Article

References (74)

1. Esterbauer H., Gebicki J., Puhl H., Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
2. Heinecke J.W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74:1984;1890-1894.
3. Kuzuya M., Yamada K., Hayashi T., Funaki C., Naito M., Asai K., Kuzuya F. Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. Biochim. Biophys. Acta. 1123:1992;334-341.
4. Watson A.D., Navab M., Hama S.Y., Sevanian A., Prescott S.M., Stafforini D.M., McIntyre T.M., Du B.N., Fogelman A.M., Berliner J.A. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95:1995;774-782.
5. Noguchi N., Gotoh N., Niki E. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals. Biochim. Biophys. Acta. 1213:1994;176-182.
6. Itabe H., Kobayashi T., Inoue K. Generation of toxic phospholipid(s) during oxyhemoglobin-induced peroxidation of phosphatidylcholines. Biochim. Biophys. Acta. 961:1988;13-21.
7. Foote C.S. Photosensitized oxidation and singlet oxygen consequences in biological systems. Pryor W.A. Free radicals in biology. 1976;85-134 Academic Press, New York.
8. Steinbrecher U.P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262:1987;3603-3608.
9. Stremler K.E., Stafforini D.M., Prescott S.M., Zimmerman G.A., McIntyre T.M. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J. Biol. Chem. 264:1989;5331-5334.
10. Steinbrecher U.P., Pritchard P.H. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J. Lipid Res. 30:1989;305-315.
11. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:1995;2882-2891.
12. Kayganich-Harrison K.A., Murphy R.C. Characterization of chain-shortened oxidized glycerophosphocholine lipids using fast atom bombardment and tandem mass spectrometry. Anal. Biochem. 221:1994;16-24.
13. Hall L.M., Murphy R.C. Analysis of stable oxidized molecular species of glycerophospholipids following treatment of red blood cell ghosts with t-butylhydroperoxide. Anal. Biochem. 258:1998;184-194.
14. Watson A.D., Leitinger N., Navab M., Faull K.F., Horkko S., Witztum J.L., Palinski W., Schwenke D., Salomon R.G., Sha W., Subbanagounder G., Fogelman A.M., Berliner J.A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272:1997;13597-13607.
15. Wolfgang G.H., Jolly R.A., Donarski W.J., Ochoa R., Petry T.W. Inhibition of carbon tetrachloride-induced lipid peroxidation by novel antioxidants in rat hepatic microsomes dissociation from hepatoprotective effects in vivo . J. Biochem. Toxicol. 5:1990;167-174.
16. Hughes H., Smith C.V., Horning E.C., Mitchell J.R. High-performance liquid chromatography and gas chromatography-mass spectrometry determination of specific lipid peroxidation products in vivo. Anal. Biochem. 130:1983;431-436.
17. Guido D.M., McKenna R., Mathews W.R. Quantitation of hydroperoxy-eicosatetraenoic acids and hydroxy-eicosatetraenoic acids as indicators of lipid peroxidation using gas chromatography-mass spectrometry. Anal. Biochem. 209:1993;123-129.
18. Yoshida, L. S.; Miyazawa, T.; Fujimoto, K.; Kaneda, T. Spontaneous and luminol-dependent chemiluminescences from tissue preparations of benzo[a]pyrene-injected mice. J. Nutr. Sci. Vitaminol. (Tokyo) 35:569-578; 1989.
19. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-918.
20. Folch J., Lees M., Slone Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
21. Rose F., Oklander R. Improved procedure for the extraction of lipids from human erythrocytes. J. Lipid Res. 6:1965;428-431.
22. Nakamura T., Henson P.M., Murphy R.C. Occurrence of oxidized metabolites of arachidonic acid esterified to phospholipids in murine lung tissue. Anal. Biochem. 262:1998;23-32.
23. Radin N.S. Extraction of tissue lipids with a solvent of low toxicity. Methods Enzymol. 72:1981;5-7.
24. Siess W., Zangl K.J., Essler M., Bauer M., Brandl R., Corrinth C., Bittman R., Tigyi G., Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 96:1999;6931-6936.
25. Kaluzny M.A., Duncan L.A., Merritt M.V., Epps D.E. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J. Lipid Res. 26:1985;135-140.
26. Salari H. Comparative study of solid-phase and liquid-phase extraction techniques for isolation of phospholipids from plasma. J. Chromatogr. 419:1987;103-111.
27. Eskra J.D., Pereira M.J., Ernest M.J. Solid-phase extraction and high-performance liquid chromatography analysis of lipoxygenase pathway products. Anal. Biochem. 154:1986;332-337.
28. Touchstone J.C., Chen J.C., Beaver K.M. Improved separation of phospholipids in thin layer chromatography. Lipids. 15:1980;61-62.
29. El Tamer A., Record M., Fauvel J., Chap H., Douste-Blazy L. Studies on ether phospholipids. I. A new method of determination using phospholipase A1 from guinea pig pancreas application to Krebs II ascites cells . Biochim. Biophys. Acta. 793:1984;213-220.
30. Chen J.P.S., Toribara T.Y., Warner H. Microdetermination of phosphorus. Anal. Chem. 28:1956;1756-1758.
31. Kim H.Y., Wang T.C., Ma Y.C. Liquid chromatography/mass spectrometry of phospholipids using electrospray ionization. Anal. Chem. 66:1994;3977-3982.
32. Han X.L., Gross R.W. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc. Natl. Acad. Sci. USA. 91:1994;10635-10639.
33. Hall L.M., Murphy R.C. Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids. J. Am. Soc. Mass Spectrom. 9:1998;527-532.
34. Kaduce T.L., Norton K.C., Spector A.A. A rapid, isocratic method for phospholipid separation by high-performance liquid chromatography. J. Lipid Res. 24:1983;1398-1403.
35. Watson A.D., Subbanagounder G., Welsbie D.S., Faull K.F., Navab M., Jung M.E., Fogelman A.M., Berliner J.A. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. J. Biol. Chem. 274:1999;24787-24787.
36. Wratten M.L., van Ginkel G., van't Veld A.A., Bekker A., van Faassen E.E., Sevanian A. Structural and dynamic effects of oxidatively modified phospholipids in unsaturated lipid membranes. Biochemistry. 31:1992;10901-10907.
37. van Ginkel G., Sevanian A. Lipid peroxidation-induced membrane structural alterations. Methods Enzymol. 233:1994;273-288.
38. Wratten M.L., Gratton E., van de Ven M., Sevanian A. DPH lifetime distributions in vesicles containing phospholipid hydroperoxides. Biochem. Biophys. Res. Commun. 164:1989;169-175.
39. Sugatani J., Fujimura K., Miwa M., Satouchi K., Saito K. Molecular heterogeneity of platelet-activating factor (PAF) in rat glandular stomach determined by gas chromatography/mass spectrometry. PAF molecular species changes upon water-immersion stress. Lipids. 26:1991;1347-1353.
40. Subbanagounder G., Salomon R.G., Murthi K.K., Brame C., Roberts L.J. Total synthesis of Iso[4]-levuglandin E-2. J. Org. Chem. 62:1997;7658-7666.
41. Harrison K.A., Murphy R.C. Isoleukotrienes are biologically active free radical products of lipid peroxidation. J. Biol. Chem. 270:1995;17273-17278.
42. Mortan D., Thompson J. Total synthesis of 3-oxa-4,5,6-trinor-3,7-inter-m-phenylene prostaglandins. 2. Conjugate addition approach. J. Org. Chem. 43:1978;2102-2106.
43. Silverstein, R.; Bassler, G.; Morrill, T. Spectrometric identification of organic compounds (3rd edn.). New York: John Wiley & Sons, Inc.; 1991.
44. Andersen N.H., Hartzell C.J. High-field 1H NMR studies of prostaglandin H2 and its decomposition pathways. Biochem. Biophys. Res. Commun. 120:1984;512-519.
45. Mahmud I., Smith D.L., Whyte M.A., Nelson J.T., Cho D., Tokes L.G., Alvarez R., Willis A.L. On the identification and biological properties of prostaglandin J2. Prostaglandin Leukot. Med. 16:1984;131-146.
46. Bogaards J.J., Venekamp J.C., van Bladeren P.J. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1. Chem. Res. Toxicol. 10:1997;310-317.
47. Sparling M.L., Zidovetzki R., Muller L., Chan S.I. Analysis of membrane lipids by 500 MHz 1H NMR. Anal. Biochem. 178:1989;67-76.
48. Choi G.T., Casu M., Gibbons W.A. N.m.r. lipid profiles of cells, tissues and body fluids. Neutral, non-acidic and acidic phospholipid analysis of Bond Elut chromatographic fractions. Biochem. J. 290:1993;717-721.
49. Ravandi A., Kuksis A., Myher J.J., Marai L. Determination of lipid ester ozonides and core aldehydes by high-performance liquid chromatography with on-line mass spectrometry. J. Biochem. Biophys. Methods. 30:1995;271-285.
50. Mallat Z., Nakamura T., Ohan J., Leseche G., Tedgui A., Maclouf J., Murphy R.C. The relationship of hydroxyeicosatetraenoic acids and F-2-isoprostanes to plaque instability in human carotid atherosclerosis. J. Clin. Invest. 103:1999;421-427.
51. Cole M.J., Enke C.G. Direct determination of phospholipid structures in microorganisms by fast atom bombardment triple quadrupole mass spectrometry. Anal. Chem. 63:1991;1032-1038.
52. Hara A., Taketomi T. Characterization and change of phospholipids in the aorta of Watanabe hereditable hyperlipidemic rabbit. Jpn. J. Exp. Med. 60:1990;311-318.
53. Leitinger N., Watson A.D., Hama S.Y., Ivandic B., Qiao J.H., Huber J., Faull K.F., Grass D.S., Navab M., Fogelman A.M., de Beer F.C., Lusis A.J., Berliner J.A. Role of group II secretory phospholipase A(2) in atherosclerosis - 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 19:1999;1291-1298.
54. Subbanagounder G., Leitinger N., Shih P.T., Faull K.F., Berliner J.A. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis - in vitro and in vivo inhibition by WEB 2086. Circ. Res. 85:1999;311-318.
55. Leitinger N., Oslund L.P., Tyner T.R., Rizza C., Subbanagounder G., Lee H., Shih P.T., Mackman N., Tigyi G., Berliner J.A., Vora D.K. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl. Acad. Sci. USA. 96:1999;12010-12015.
56. Hörkkö S., Bird D.A., Miller E., Itabe H., Leitinger N., Subbanagounder G., Berliner J.A., Friedman P., Dennis E.A., Curtiss L.K., Palinski W., Witztum J.L. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103:1999;117-128.
57. Heery J.M., Kozak M., Stafforini D.M., Jones D.A., Zimmerman G.A., McIntyre T.M., Prescott S.M. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J. Clin. Invest. 96:1995;2322-2330.
58. Bird D.A., Gillotte K.L., Hörkkö S., Friedman P., Dennis E.A., Witztum J.L., Steinberg D. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties implications with respect to macrophage recognition of apoptotic cells . Proc. Natl. Acad. Sci. USA. 96:1999;6347-6352.
59. Chang M.K., Bergmark C., Laurila A., Hörkkö S., Han K.H., Friedman P., Dennis E.A., Witztum J.L. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages evidence that oxidation-specific epitopes mediate macrophage recognition . Proc. Natl. Acad. Sci. USA. 96:1999;6353-6358.
60. Itabe H., Yamamoto H., Suzuki M., Kawai Y., Nakagawa Y., Suzuki A., Imanaka T., Takano T. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein. J. Biol. Chem. 271:1996;33208-33217.
61. Demopoulos C.A., Pinckard R.N., Hanahan D.J. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254:1979;9355-9358.
62. Blank M.L., Snyder F., Byers L.W., Brooks B., Muirhead E.E. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem. Biophys. Res. Commun. 90:1979;1194-1200.
63. Benveniste J., Henson P.M., Cochrane C.G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J. Exp. Med. 136:1972;1356-1377.
64. Kern H., Volk T., Knauer-Schiefer S., Mieth T., Rüstow B., Kox W.J., Schlame M. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group. Biochim. Biophys. Acta. 1394:1998;33-42.
65. Zimmerman G.A., Prescott S.M., McIntyre T.M. Oxidatively fragmented phospholipids as inflammatory mediators the dark side of polyunsaturated lipids . J. Nutr. 125:1995;1661S-1665S.
66. Frostegård J., Huang Y.H., Rönnelid J., Schäfer-Elinder L. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism. Arterioscler. Thromb. Vasc. Biol. 17:1997;963-968.
67. Itabe H., Kushi Y., Handa S., Inoue K. Identification of 2-azelaoylphosphatidylcholine as one of the cytotoxic products generated during oxyhemoglobin-induced peroxidation of phosphatidylcholine. Biochim. Biophys. Acta. 962:1988;8-15.
68. Quinn M.T., Parthasarathy S., Steinberg D. Lysophosphatidylcholine a chemotactic factor for human monocytes and its potential role in atherogenesis . Proc. Natl. Acad. Sci. USA. 85:1988;2805-2809.
69. Mangin E.L. Jr, Kugiyama K., Nguy J.H., Kerns S.A., Henry P.D. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ. Res. 72:1993;161-166.
70. Kume N., Cybulsky M.I., Gimbrone M.A. Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90:1992;1138-1144.
71. Ramos M.A., Kuzuya M., Esaki T., Miura S., Satake S., Asai T., Kanda S., Hayashi T., Iguchi A. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 18:1998;1188-1196.
72. Schulze C., Smales C., Rubin L.L., Staddon J.M. Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells. J. Neurochem. 68:1997;991-1000.
73. Colangelo S., Langille B.L., Steiner G., Gotlieb A.I. Alterations in endothelial F-actin microfilaments in rabbit aorta in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 18:1998;52-56.
74. Rizza, C.; Leitinger, N.; Yue, J.; Fischer, D.; Wang, D.; Shih, P.; Lee, H.; Tigyi, G.; Berliner, J.LPA as a regulator of endothelial/leukocyte interaction. Lab. Invest. 79:1227-1235; 1999.